UNSPSC 51142553: Lazabemide monohydrochloride

This classification denotes a monoamine oxidase inhibitor with the molecular formula C8H10ClN3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PI150J9ZX1, chemically known as n-(2-aminoethyl)-5-chloro-2-pyridine-carboxamide hydrochloride, but more generally known as lazabemide monohydrochloride, which bears US NIH Compound Identifier 163727. European Medicines Agency schedules lazabemide monohydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08418MIG.

Most nations, for tariff purposes, schedule lazabemide monohydrochloride under HS 29333999. SMILES: C1CC(NCC1CL)C(=O)NCCN.CL.

UNSPSC 51142553 Lazabemide monohydrochloride is a Commodity code that in state and local procurement practice covers pharmaceutical and chemical compounds used in public health and emergency response programs. The code appears in recent solicitations focused on opioid-response and harm-reduction initiatives, where state and local health departments and county public-health agencies procure naloxone, drug deactivation systems, and related pharmaceutical supplies to support community health and overdose-prevention efforts. Issuing bodies under this code include county health departments and public-health agencies pursuing competitive bidding for multi-unit pharmaceutical acquisitions on regular supply schedules. The scope encompasses both the active pharmaceutical ingredient itself and integrated delivery or safety systems used in public emergency response.

Seminole County, Florida, posted an IFB in June 2026 (IFB60459723LAS) seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The county required electronic bid submission through its e-Procurement Portal, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, and standard commercial insurance. The contract structure included a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination without cause. The solicitation indicated potential FEMA funding and compliance with federal environmental regulations. The code shows minimal recent activity in state and local databases, and the single posted opportunity—while tagged under this Commodity code—centers primarily on naloxone and drug deactivation systems procurement rather than lazabemide monohydrochloride specifically, suggesting potential misclassification or specialized pharmaceutical procurement limited to particular jurisdictions.